⌕
Tyra Biosciences · TYRA · Nasdaq
Tenet 65 · Solid
Compare
$19.57−0.86%At closeTenet 65 · Solid
$19.57−0.17 (−0.86%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Tyra Biosciences (TYRA) Institutional Ownership

13F filers reported holding 41.2% of Tyra Biosciences (TYRA) shares as of Sep 30, 2026, across 101 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice
Held by 13F filers
41.2%
Sep 30, 2026
13F filers
101
quarter ended Sep 30, 2026
13F value
$622.1M
28.5M shares
Quarter's fund flow
Mild accumulation
14 new · 15 closed

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Sep 30, 2026: more funds added or entered than trimmed or exited, mild accumulation (14 new · 38 increased · 35 reduced · 15 closed). Flows at this scale move slowly; treat as context. These positions are 49 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 101 13F filers for Sep 30, 2026, over shares outstanding implied from the current quote, measured 49 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Sep 15, 2026Harris ToddPresident and CEOAcquired · Grant / award864$9.13↗
Sep 15, 2026Rueb YuliyaVice President, Finance (PAO)Acquired · Grant / award2,925$9.13↗
Sep 15, 2026Fuhrman AlanChief Financial OfficerAcquired · Grant / award951$9.13↗
Sep 9, 2026Verjee RehandirectorAcquired · Open-market buy972$20.58↗
May 28, 2026RA CAPITAL MANAGEMENT, LLCdirectorAcquired · Grant / award13,160Stock Option (Right to Buy)—↗
May 28, 2026Verjee RehandirectorAcquired · Grant / award13,160Stock Option (Right to Buy)—↗
May 28, 2026Moran SusandirectorAcquired · Grant / award13,160Stock Option (Right to Buy)—↗
May 28, 2026Simson JakedirectorAcquired · Grant / award13,160Stock Option (Right to Buy)—↗
May 28, 2026Gulfo Adele M.directorAcquired · Grant / award13,160Stock Option (Right to Buy)—↗
May 28, 2026MORE ROBERT JdirectorAcquired · Grant / award13,160Stock Option (Right to Buy)—↗
May 28, 2026Rothenberg Stephen MichaeldirectorAcquired · Grant / award13,160Stock Option (Right to Buy)—↗
May 5, 2026Warner Douglas JChief Medical OfficerAcquired · Grant / award25,000—↗
May 5, 2026Warner Douglas JChief Medical OfficerAcquired · Grant / award85,000Stock Option (Right to Buy)—↗
May 5, 2026Fuhrman AlanChief Financial OfficerAcquired · Grant / award20,000—↗
May 5, 2026Fuhrman AlanChief Financial OfficerAcquired · Grant / award67,000Stock Option (Right to Buy)—↗
May 5, 2026Harris ToddPresident and CEOAcquired · Grant / award79,000—↗
May 5, 2026Harris ToddPresident and CEOAcquired · Grant / award265,000Stock Option (Right to Buy)—↗
May 5, 2026Ashar BhaveshChief Operating OfficerAcquired · Grant / award15,013—↗
May 5, 2026Ashar BhaveshChief Operating OfficerAcquired · Grant / award50,295Stock Option (Right to Buy)—↗
May 5, 2026Rueb YuliyaVice President, Finance (PAO)Acquired · Grant / award8,333—↗

* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of Tyra Biosciences do institutions hold?

13F filers reported holding 41.2% of Tyra Biosciences' shares as of Sep 30, 2026, across 101 filers.

How many 13F filers hold Tyra Biosciences?

Tyra Biosciences was held by 101 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.